Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland (STARR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03299569|
Recruitment Status : Recruiting
First Posted : October 3, 2017
Last Update Posted : October 3, 2017
|Condition or disease|
|Takotsubo Cardiomyopathy Myocardial Infarction|
Each centre put in place two methods of identification of past Tako-tsubo caes:
- Each local PI received a NSS list containing CHI numbers of all patients coded under Code I42.8, which is for "Other Cardiomyopathies" in the ICD 10 system.
- Each local PI also enabled a search method in their cardiac catheterisation reporting software in order to identify remaining cases.
The Research Fellow travels to the designated sites to carry out the following work:
- Cross-check all electronic records of all CHI numbers returned from the NSS to identify only the Tako-tsubo cases from all cases returned under Code I42.8 to each individual local PI.
- Carry out searches in the cardiac catheterisation software of each hospital to identify the remaining cases.
- Identify an equal number of MI controls from within the Grampian area.
We will collect clinical data off all Tako-tsubo patients retrospectively and prospectively. The STARR study will benefit from the unique electronic linkage of health records in Scotland.
The STARR study database will be used as a stepping stone to large epidemiology and mechanistic studies.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||800 participants|
|Target Follow-Up Duration:||13 Years|
|Official Title:||Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland - the STARR Study|
|Actual Study Start Date :||July 29, 2016|
|Estimated Primary Completion Date :||December 31, 2023|
|Estimated Study Completion Date :||December 31, 2023|
All patients diagnosed with Takotsubo cardiomyopathy in Scotland since 2010.
An equal number of myocardial infarction patients in NHS Grampian since 2010.
- Identify number of Takotsubo cases in Scotland [ Time Frame: 13 years ]Identify number of Takotsubo cases in Scotland
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03299569
|Contact: Dana Dawson, MD, MRCP||01224 email@example.com|
|Contact: Amelia Rudd, HND||01224 firstname.lastname@example.org|
|Cardiac Research Office||Recruiting|
|Aberdeen, Scotland, United Kingdom, AB25 2ZD|
|Contact: Amelia Rudd, HND 01224 559573 email@example.com|
|Principal Investigator:||Dana Dawson, MD, MRCP||University of Aberdeen|